Chemotherapy: Rolapitant reduces nausea and vomiting in phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial.



from Latest Science News -- ScienceDaily http://ift.tt/1ny1YXB